The attenuation of ADAMTS-4 expression by TGF-β is consistent with an anti-atherogenic plaque-stabilising role for TGF-β within atherosclerosis and backs up findings from a previous publication [16]. The gene discussed is TGFB1; the disease is atherosclerosis.